Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Telescope Announces Appointment of Dr. E. Neil Lewis to the Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company" or "Telescope"), a leading developer of Physical AI systems, including Self-Driving Laboratories, and enabling technologies and services for the global pharmaceutical and high-value chemical industries, is pleased to announce the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026. Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA.